off-label use of glp-1 agonists for obesity in 2016 Chart: 1 8 Americans Now Drugs Weight Loss GLP1 Receptor Agonists—Effects beyond Obesity

GLP-1 Medications: Work with natural hunger hormones Multiple complementary mechanisms Target biological causes of overeating Produce 10-22% average weight loss Much more effective than traditional options Medical Uses: FDA-Approved Indications: For Type 2 Diabetes: All GLP-1 medications originally approved for diabetes Improve blood sugar control Reduce A1C by 1-2 percentage points Lower risk of cardiovascular events For Chronic Weight Management: Semaglutide (Wegovy): Approved 2021 Tirzepatide (Zepbound): Approved 2023 Liraglutide (Saxenda): Approved 2014 Requirements for weight loss approval: BMI 30, or BMI 27 with weight-related condition (diabetes, hypertension, sleep apnea, etc.) Off-Label Use: Many doctors prescribe diabetes versions (Ozempic, Mounjaro) off-label for weight loss because: Identical medication to weight loss versions Sometimes better insurance coverage Same effectiveness regardless of indication on label This is legal and common medical practice

ClearLifts high-powered Q-switched laser can operate 2 different wavelengths to be effective with darker colors breaking down the ink particles without causing damage to the skin using very short laser pulses to target only the pigment in the ink

Insulin-like growth factor in muscle growth and its potential abuse by athletes

Country Life L-Carnitine 500 mg B6

Metformin: Metformin primarily reduces glucose production in the liver and enhances the bodys response to insulin